Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Receive the latest news and breaking updates, straight from our newsroom to your inbox.
Wegovy can harm an unborn baby and may enter breast milk
The peptide remains in Phase 3 clinical trials with Eli Lilly, with potential FDA approval expected sometime in late 2026 or early 2027
Background Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are a class of medications initially developed to treat type 2 diabetes (T2D) and obesity
Your next refill is approved after your required 3-month provider check-in (don't worry, we'll email you when it's time!)
US$ 22.13
US$ 20.70
US$ 20.01
US$ 25.79
US$ 29.20
US$ 29.27
